Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit

Journal of Hospital Infection

Volumn 72, Issue 3, 2009, Pages 234-242

  Jamal, W ^a   Salama, M ^a   Dehrab, N ^a   Al Hashem, G ^a   Shahin, M ^a   Rotimi, V O ^a  

^a MUBARAK AL KABEER HOSPITAL   (Kuwait)

Author keywords

Acinetobacter spp.; Carbapenem resistance; Intensive care unit; Outbreak; Tigecycline

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEVICE; EPSILOMETER TEST; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; MEDICAL INSTRUMENTATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTIDRUG RESISTANCE; PULSED FIELD GEL ELECTROPHORESIS; SCREENING; SURFACE PROPERTY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENVIRONMENTAL MICROBIOLOGY; EPIDEMIOLOGY, MOLECULAR; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE; YOUNG ADULT;

EID: 67349128949     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.03.023     Document Type: Article

References (28)

1. Chastre J., and Trouillet J.L. Problem pathogens (Pseudomonas and Acinetobacter). Semin Respir Infect 15 (2000) 287-298
2. Rello J., Diaz E., and Rodrigues A. Etiology of ventilator-associated pneumonia. Clin Chest Med 26 (2005) 87-95
3. Bergogne-Berezin E. Acinetobacter species. In: Cohen Y., Weber R., and Raoult D. (Eds). Antimicrobial therapy and vaccines (2002), Apple Trees Production, New York 11-18
4. Theaker C., Azdian B., and Soni N. The impact of Acinetobacter baumannii in the intensive care unit. Anaesthesia 58 (2003) 271-274
5. Rodriquez-Bano J., Cisneros J.M., Fernandez-Cuenca F., et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 25 (2004) 819-824
6. Bergogne-Berezin E., and Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 9 (1996) 148-165
7. Dalla Costa L.M., Coelhojm J.M., Souza H.A., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 enzyme in Curitha, Brazil. J Clin Microbiol 41 (2003) 3403-3406
8. Manuel R.J., Yen Shin G., Farrag N., and Holliman R. Endemic carbapenem-resistant Acinetobacter baumannii in a London hospital. J Antimicrob Chemother 52 (2003) 141-142
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. M100-S17 (2007), CLSI, Baltimore, MA
10. Heritier C.A., Dubouix L., Poirel L., Marty N., and Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother 55 (2005) 115-118
11. Tenover F.C., Arbeit R., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
12. Donald H.M., Scaife W., Amyes S.G., and Young H. Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrobial Agents Chemother 44 (2000) 196-199
13. Tankovic J., Legrand P., de Gatines G., et al. Characterization of a hospital out-break of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 32 (1994) 2677-2681
14. Naas T., Levy M., Hirschauer C., Marchandin, and Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 43 (2005) 4826-4829
15. Bou G., Cervero G., Dominguez M.A., Qureda C., and Martinez-Beltran J. Characterization of a nosocomial out-break caused by a multiresistant Acinetobacter baumannii with carbapenem-hydrolyzing enzymes: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol 38 (2000) 3299-3305
16. Afzal-Shah M., and Livermore D.M. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother 41 (1998) 576-577
17. Jeon B.C., Jeong S.H., Bae I.K., et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23β-lactamase in Korea. J Clin Microbiol 43 (2005) 2241-2245
18. Costa S.F., Woodcook J., Gill M., et al. Outer-membrane protein pattern and detection of β-lactamase in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil. Int J Antimicrob Agents 13 (2000) 175-182
19. Clark R.B. Imipenem resistance among Acinetobacter baumannii associated with reduced expression of a 33-36 kDa outer-protein. J Antimicrob Chemother 38 (1996) 245-251
20. Landman D., Quale J.M., Mayorga D., et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn NY; the preantibiotic era has returned. Arch Intern Med 162 (2002) 1515-1520
21. Scerpella E.G., Wanger A.R., Armitige L., Anderlini P., and Ericsson C.D. Nosocomial out-break caused by a multiresistant clone of Acinetobacter baumannii; results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 16 (1995) 92-97
22. Pankuch G.A., and Appelbaum P.G. Post antibiotic effect of tigecycline against Gram-positive organisms. Antimicrobial Agents Chemother (2008) 8 Dec (Epub ahead of print)
23. Peleg A.Y., Potoski B.A., Rea R., et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline. J Antimicrob Chemother 59 (2007) 128-131
24. Enoch D.A., Summers C., Brown M.M., et al. Investigation and management of an outbreak of multi-drug resistant Acinetobacter baumannii in Cambridge, UK. J Hosp Infect 70 (2008) 109-118
25. Mullin B., Talon D., Viel J.F., et al. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 14 (1995) 569-576
26. Koeleman J.G., Van Der Bijl M.W., Stoof J., Vandenbroucke-Grauls C.M., and Savelkoul P.H. Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii. Infect Control Hosp Epidemiol 22 (2001) 284-288
27. Poirel L., Menuteau O., Agoli N., Cattoen C., and Nordmann P. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French Hospital. J Clin Microbiol 41 (2003) 3542-3547
28. Villers D., Espaze E., Coste-Burel M., et al. Nosocomial Acinetobacter baumannii infections; microbiological and clinical epidemiology. Ann Intern Med 129 (1998) 182-189